William Blair Reiterates Outperform Rating on Tenax Therapeutics (TENX): "continue to believe positive top-line results from LEVEL have the potential to drive multifold upside"
Tweet Send to a Friend
William Blair analyst Matt Phipps reiterated an Outperform rating on Tenax Therapeutics (NASDAQ: TENX)The analyst commented, "Before the market open ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
